Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q4 2021)
11,000
Value
$468.0K
% of portfolio
0.1%
Quarters held
2
Since Q3 2021
Holdings of SAGE by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 2022––––Not filedHolders
Q4 202111,000$468.0K0.1%+5,000+83.3%AddedHolders
Q3 20216,000$266.0K0.1%+6,000NewHolders